fludarabine and Leukemia, Pre-B-Cell

fludarabine has been researched along with Leukemia, Pre-B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Chen, Y; Li, J; Li, Z; Liu, F; Liu, L; Pui, CH; Ruan, M; Wang, J; Wang, S; Wang, Y; Yang, JJ; Zhong, M; Zhu, X	1

Trials

1 trial(s) available for fludarabine and Leukemia, Pre-B-Cell

Article	Year
Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells. Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Humans; Immunotherapy, Adoptive; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Testicular Neoplasms; Vidarabine	2020

Article

Year

Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells.

Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Humans; Immunotherapy, Adoptive; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Testicular Neoplasms; Vidarabine

2020